Hematology
Surbhi Sidana, M.D.
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Dr. Surbhi Sidana is an Associate Professor of Medicine at Stanford University specializing in multiple myeloma and related blood disorders. She leads the Myeloma CAR-T/Immunotherapy program at Stanford and directs the Myeloma Disease Focused Group within the BMT and Cell Therapy Division. Her clinical expertise encompasses multiple myeloma, amyloidosis, POEMS syndrome, Waldenstrom's macroglobulinemia, and cryoglobulinemia, with particular focus on novel cellular immunotherapies including CAR-T
15+
Years in Practice
Credentials
Board Certifications
- Internal Medicine (American Board of Internal Medicine)
- Hematology (American Board of Internal Medicine)
- Medical Oncology (American Board of Internal Medicine)
Education & Training
- Maulana Azad Medical College, University of Delhi, India
- Cleveland Clinic Foundation — Residency, Internal Medicine, 2012–2015
- Mayo Clinic College of Medicine and Science — Fellowship, Hematology and Medical Oncology, 2015–2018
- Mayo Clinic College of Medicine and Science — Advanced Fellowship, Hematology (Myeloma, Amyloidosis, and Related Disorders), 2018–2019
Recognition & Leadership
Awards & Honors
- Exemplary Abstract Award, International Myeloma Society (2023)
- Merit Award, American Society of Clinical Oncology/Conquer Cancer Foundation (2019)
- Hematology/Oncology Outstanding Fellow, Mayo Clinic, Rochester, MN (2018)
- Junior Researcher Travel Award, Amyloidosis Foundation (2018)
- Outstanding Research Fellow, Department of Medicine, Mayo Clinic, Rochester, MN (2018)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Stanford Health Care
- Stanford Cancer Institute
- Pelvic Health Center, Stanford University School of Medicine
Languages
English
Experience
15+ years in practice